Trials / Unknown
UnknownNCT05432050
Bispectral Index and Patient State Index During General Anesthesia With Remimazolam
Bispectral Index and Patient State Index During General Anesthesia With Remimazolam: a Prospective Observational Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (estimated)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- —
Summary
The aim of this study is to compare the bispectral index (BIS) and patient state index (PSI) during general anesthesia using remimazolam. The infusion rate of remimazolam is 6-12mg/kg/h during induction of anesthesia and 1-2mg/kg/h during maintenance of anesthesia. To calculate the fraction, the sum of times when BIS\<60 and PSI \<50 will be divided by the time from the loss of consciousness during induction of anesthesia to fully awake during emergence. We will compare the fraction of BIS \<60 and the fraction of PSI \<50 to find if there is some difference between the two depth of anesthesia monitoring devices during remimazolam anesthesia.
Conditions
- Remimazolam
- Anesthesia, General
- Hypnotics and Sedatives
- Thyroid Disease
- Breast Diseases
- Parathyroid Diseases
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Bispectral index and Patient state index monitoring | The depth of anesthesia will be monitored with both the bispectral index and patient state index at the same time. |
Timeline
- Start date
- 2022-07-01
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
- First posted
- 2022-06-27
- Last updated
- 2022-07-01
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05432050. Inclusion in this directory is not an endorsement.